These data reinforce the potential clinical benefits of long-term therapy for people living with obesity and pre-diabetes. SURMOUNT-1 (NCT04184622) was a multi-center, randomized, double-blind, parallel, placebo-controlled trial comparing 5 mg, 10 mg, and 15 mg of tirzepatide to placebo as an adjunct to a reduced-calorie diet and increased physical activity in adults with pre-diabetes and obesity or overweight with at least 1 of the following comorbidities: hypertension, dyslipidemia, obstructive sleep apnea, or cardiovascular disease
Nausea Diarrhea Abdominal pain Vomiting Constipation One of the bad side effects of Ozempic, gastroparesis, is not listed on the drugs prescribing information
You should not donate plasma if you have injected drugs, steroids, or other substances not prescribed by a doctor in the last three months or if you have engaged in sex for money or drugs in the last three months
Tirzepatide doses range from 2.5 mg to 15 mg
medRxiv , 2025.03.06.25323524 (2025).
Renoprotective effects of combination treatment with sodium-glucose cotransporter inhibitors and GLP-1 receptor agonists in patients with type 2 diabetes mellitus according to preceding medication